BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 53 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -85.7% | 13,561 | -66.0% | 0.00% | – |
| Q2 2022 | $21,000 | -98.6% | 39,900 | -94.5% | 0.00% | – |
| Q1 2022 | $1,492,000 | -34.3% | 727,599 | +33.5% | 0.00% | – |
| Q4 2021 | $2,271,000 | +2241.2% | 544,881 | +5177.3% | 0.00% | – |
| Q3 2021 | $97,000 | -67.6% | 10,325 | -37.7% | 0.00% | – |
| Q2 2021 | $299,000 | – | 16,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |